Playlist

A 110-Year Milestone Celebrated in Dashoguz Velayat of Turkmenistan Ahead of the New Year

03 Jan. 10:06

Source

On the eve of the New Year, a remarkable celebration took place in the Akdepe district of Dashoguz velayat, Turkmenistan. Local resident Novar Gylyjova marked her 110th birthday surrounded by family members, neighbors, and fellow villagers who gathered to honor her extraordinary life journey.

In Turkmenistan, Novar-ene is regarded as a symbol of family unity and moral strength. Over the decades, she raised five children and became the grandmother of sixteen grandchildren and the great-grandmother of six great-grandchildren, with the family continuing to grow.

Her family is especially respected in the village for its contribution to education in Turkmenistan. Many of her children and grandchildren chose teaching as their profession, earning the household a reputation as a “family of educators.” One of her sons has devoted more than half a century to working as a school teacher, helping shape future generations.

Throughout her life, Novar Gylyjova worked in agriculture, remaining closely connected to the land. She attributes her long life to honest labor, positive intentions, and unwavering care for her children. During holidays, the extended family traditionally comes together, maintaining close ties despite distances — a value deeply rooted in Turkmenistan’s cultural heritage.

Extending her New Year wishes to the people of Turkmenistan, the 110-year-old resident wished everyone good health, prosperity, and many peaceful years ahead.

‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌

Simple Vitamin Shows Surprising Results in Pre-Cancerous Blood Conditions, Study Finds

Today in 02:02

Source

Daily high-dose supplementation of vitamin C can significantly reduce mortality risks and help prevent severe medical complications in patients with pre-cancerous blood conditions. Researchers from the Van Andel Institute in the United States and Copenhagen University Hospital in Denmark reached this conclusion following a comprehensive three-year follow-up study. The international "EVITA" trial involved volunteers who were administered 1,000 mg of vitamin C daily over the course of a year, while a control group received a placebo.

Although initial hypotheses suggested vitamin C might directly inhibit abnormal cell proliferation, researchers found its primary benefit lay in strengthening the body, reducing systemic inflammation, and lowering rates of anemia, pneumonia, and internal bleeding. Over the three-year observation period, the vitamin C group exhibited a significantly higher survival rate compared to the placebo group. While experts emphasize that these findings remain preliminary and require larger clinical trials before reshaping formal medical treatment protocols, vitamin C continues to show promising potential in supportive patient care.

‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌